Scientific Letter
Familial lymphohistiocytosis, the importance of recognizing the infrequent
Linfohistiocitosis familiar, la importancia de reconocer lo infrecuente
Read
1039
Timeswas read the article
409
Total PDF
630
Total HTML
Share statistics
array:24 [ "pii" => "S2341287923002235" "issn" => "23412879" "doi" => "10.1016/j.anpede.2023.09.009" "estado" => "S300" "fechaPublicacion" => "2023-11-01" "aid" => "3490" "copyright" => "Asociación Española de Pediatría" "copyrightAnyo" => "2023" "documento" => "article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "An Pediatr (Barc). 2023;99:354-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S1695403323001595" "issn" => "16954033" "doi" => "10.1016/j.anpedi.2023.07.004" "estado" => "S300" "fechaPublicacion" => "2023-11-01" "aid" => "3490" "copyright" => "Asociación Española de Pediatría" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "An Pediatr (Barc). 2023;99:354-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENTÍFICA</span>" "titulo" => "Linfohistiocitosis familiar, la importancia de reconocer lo infrecuente" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "354" "paginaFinal" => "355" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Familial lymphohistiocytosis, the importance of recognizing the infrequent" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 829 "Ancho" => 2917 "Tamanyo" => 168553 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Propuesta de algoritmo diagnóstico de la HLH.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Sara Pons Morales, Carmen Carreras Gil de Santivañes, Miguel Ángel Gallego Ferrer" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Sara" "apellidos" => "Pons Morales" ] 1 => array:2 [ "nombre" => "Carmen" "apellidos" => "Carreras Gil de Santivañes" ] 2 => array:2 [ "nombre" => "Miguel Ángel" "apellidos" => "Gallego Ferrer" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2341287923002235" "doi" => "10.1016/j.anpede.2023.09.009" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287923002235?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403323001595?idApp=UINPBA00005H" "url" => "/16954033/0000009900000005/v2_202311111135/S1695403323001595/v2_202311111135/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2341287923002338" "issn" => "23412879" "doi" => "10.1016/j.anpede.2023.10.007" "estado" => "S300" "fechaPublicacion" => "2023-11-01" "aid" => "3491" "copyright" => "Asociación Española de Pediatría" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "An Pediatr (Barc). 2023;99:356-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific Letter</span>" "titulo" => "Effects of forest therapy on salivary biomarkers (cortisol, amylase and IGA) in pediatric cáncer survivors: an experimental study" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "356" "paginaFinal" => "357" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Efectos de la terapia de bosque sobre biomarcadores salivales (cortisol, amilasa e IGA) en supervivientes de cáncer pediátrico: estudio experimental" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1038 "Ancho" => 3258 "Tamanyo" => 190633 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0010" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Changes (pre vs post) in the analysed salivary biomarkers in cases and controls. The boxes (percentiles 25<span class="elsevierStyleSup">th</span>–75th) show the median concentrations of the biomarkers, and the whiskers the minimum (5th percentile) and maximum (95th percentile) values.</p> <p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">CACS, childhood and adolescent cancer survivor.</p> <p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">*Statistically significant (<span class="elsevierStyleItalic">P</span> < .05).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Francisco Díaz-Martínez, Miguel Felipe Sánchez-Sauco, Esteban Orenes-Piñero, Isabel Martínez-Romera, Juan Antonio Ortega-García" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Francisco" "apellidos" => "Díaz-Martínez" ] 1 => array:2 [ "nombre" => "Miguel Felipe" "apellidos" => "Sánchez-Sauco" ] 2 => array:2 [ "nombre" => "Esteban" "apellidos" => "Orenes-Piñero" ] 3 => array:2 [ "nombre" => "Isabel" "apellidos" => "Martínez-Romera" ] 4 => array:2 [ "nombre" => "Juan Antonio" "apellidos" => "Ortega-García" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1695403323001601" "doi" => "10.1016/j.anpedi.2023.07.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403323001601?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287923002338?idApp=UINPBA00005H" "url" => "/23412879/0000009900000005/v1_202311240521/S2341287923002338/v1_202311240521/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2341287923002223" "issn" => "23412879" "doi" => "10.1016/j.anpede.2023.07.008" "estado" => "S300" "fechaPublicacion" => "2023-11-01" "aid" => "3489" "copyright" => "Asociación Española de Pediatría" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "An Pediatr (Barc). 2023;99:351-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific Letter</span>" "titulo" => "Transfusion practices of blood products in preterm infants: National survey" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "351" "paginaFinal" => "354" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Prácticas transfusionales de hemoderivados en recién nacidos prematuros: encuesta nacional" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2420 "Ancho" => 3328 "Tamanyo" => 418775 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Current situation of PRBC transfusions in relation to the thresholds used in the ETTNO and TOP clinical trials (A) and the recommendations of the SENeo (B). Data presented in stacked bar charts showing the percentage of neonatal units that use different PRBC transfusion thresholds in different clinical scenarios and in infants with different gestational ages (weeks). In the charts at the top, the reference thresholds are those reported for the ETTNO and TOP trials: (A) at or below the restrictive (green), between the restrictive and liberal thresholds (blue) and above the liberal threshold (red). At the bottom, the thresholds correspond to the recommendations of the SENeo (B): at or below the threshold (green) and above the threshold (red). The colours of the figure can only be seen in the online version.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Laura Torrejón-Rodríguez, Alejandro Pinilla-González, Inmaculada Lara-Cantón, María Cernada, Alexandra Scrivens, Lisanne Heeger, Marta Aguar" "autores" => array:7 [ 0 => array:2 [ "nombre" => "Laura" "apellidos" => "Torrejón-Rodríguez" ] 1 => array:2 [ "nombre" => "Alejandro" "apellidos" => "Pinilla-González" ] 2 => array:2 [ "nombre" => "Inmaculada" "apellidos" => "Lara-Cantón" ] 3 => array:2 [ "nombre" => "María" "apellidos" => "Cernada" ] 4 => array:2 [ "nombre" => "Alexandra" "apellidos" => "Scrivens" ] 5 => array:2 [ "nombre" => "Lisanne" "apellidos" => "Heeger" ] 6 => array:2 [ "nombre" => "Marta" "apellidos" => "Aguar" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1695403323001583" "doi" => "10.1016/j.anpedi.2023.07.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403323001583?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287923002223?idApp=UINPBA00005H" "url" => "/23412879/0000009900000005/v1_202311240521/S2341287923002223/v1_202311240521/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific Letter</span>" "titulo" => "Familial lymphohistiocytosis, the importance of recognizing the infrequent" "tieneTextoCompleto" => true "saludo" => "Dear Editor:" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "354" "paginaFinal" => "355" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Sara Pons Morales, Carmen Carreras Gil de Santivañes, Miguel Ángel Gallego Ferrer" "autores" => array:3 [ 0 => array:4 [ "nombre" => "Sara" "apellidos" => "Pons Morales" "email" => array:1 [ 0 => "pons.sar70@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Carmen" "apellidos" => "Carreras Gil de Santivañes" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Miguel Ángel" "apellidos" => "Gallego Ferrer" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Hospital Universitario Dr. Peset, Valencia, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Hospital Universitario y Politécnico La Fe, Valencia, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Linfohistiocitosis familiar, la importancia de reconocer lo infrecuente" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 832 "Ancho" => 2923 "Tamanyo" => 182323 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0145" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Proposed diagnostic algorithm for FLH.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">A boy aged 2 years presented with fever of 6 days’ duration (40 °<span class="elsevierStyleSmallCaps">C)</span> in October 2020, without symptoms of upper respiratory tract infection or vomiting. The urine was dark and the stools were normal. The patient had not been exposed to SARS-CoV-2, there were no animals in the household and he had no history of recent travel (the family was from Pakistan and had been in Spain since March 2020). He was the single child of a healthy consanguineous couple, with no other history of interest. There had been no complications during pregnancy, delivery or the perinatal period. The patient was correctly vaccinated according to the Pakistani vaccination schedule, and this was his first episode of febrile illness.</p><p id="par0010" class="elsevierStylePara elsevierViewall">The paediatric assessment triangle indicated the patient was stable. His temperature was 39.7<span class="elsevierStyleHsp" style=""></span>°C. Other symptoms included pallor, mucosal dryness, conjunctival icterus, a murmur grade I/VI at the level of the mesocardium, normal pulses, painless hepatomegaly and palpable spleen tip. There was a small amount of tonsillar exudate and mild cervical lymph node enlargement.</p><p id="par0015" class="elsevierStylePara elsevierViewall">In addition to the SARS-CoV-2 antibody test, a complete blood count with differential and blood chemistry panel were ordered, of which the salient findings were microcytic hypochromic anaemia (red blood cells, 8<span class="elsevierStyleHsp" style=""></span>g/dL), mild neutropaenia with a normal white blood cell count and thrombopenia (75 000 platelets/mm<span class="elsevierStyleSup">3</span>) without morphological abnormalities. The Coombs test was negative. The bilirubin level was 10<span class="elsevierStyleHsp" style=""></span>mg/dL, with elevation of alanine aminotransferase (ALT, 413 IU/L; normal range: 1–55) and lactate dehydrogenase (LDH, 1176 IU/L; normal: 125–243) and decreased sodium (Na, 128 mEq/L; normal: 136–145). The urinalysis was normal. The evaluation also included an Epstein-Barr virus (EBV)/cytomegalovirus (CMV) test; testing for leishmaniasis (endemic country of origin) and a thick blood film examination. The Mantoux test reaction measured 0<span class="elsevierStyleHsp" style=""></span>mm and imaging tests evinced hepatosplenomegaly in the absence of other abnormalities.</p><p id="par0020" class="elsevierStylePara elsevierViewall">After performing the initial tests and given the presentation with decreased appetite, hepatosplenomegaly, cytopenia and hypoalbuminaemia in a patient from a region with a high burden of leishmaniasis, treatment was initiated with liposomal amphotericin B. The bone marrow (BM) examination was normal, with no evidence of haemophagocytosis or morphology suggestive of leishmaniasis. The EBV polymerase chain reaction (PCR) test turned out positive, while serological tests for detection of <span class="elsevierStyleItalic">Leishmania</span> were negative, leading to diagnosis of primary infection by EBV. The patient became afebrile within 24<span class="elsevierStyleHsp" style=""></span>h and, having ruled out leishmaniasis, treatment with amphotericin B was discontinued. At the haematological level, there were signs of BM regeneration and stabilization of haemoglobin levels from 48<span class="elsevierStyleHsp" style=""></span>h, and the patient did not require transfusion.</p><p id="par0025" class="elsevierStylePara elsevierViewall">In addition to the cytopenias and liver involvement, the evaluation evinced Hyperferritinaemia (ferritin, 7251<span class="elsevierStyleHsp" style=""></span>ng/mL; normal: 15–120) and increased levels of the soluble interleukin (IL)-2 receptor (>7500 IU/L).</p><p id="par0030" class="elsevierStylePara elsevierViewall">On account of the hepatic involvement and hypertriglyceridemia, lysosomal acid lipase deficiency was ruled out, and apolipoprotein test results were normal.</p><p id="par0035" class="elsevierStylePara elsevierViewall">The presence of fever associated with cytopenias, elevation of ferritin, LDH and soluble IL-2 receptor, hypofibrinogenaemia combined with hypertriglyceridemia, hypertransaminasaemia and hyperbilirubinaemia, despite a normal BM, suggested the diagnosis of haemophagocytic syndrome secondary to acute infection by EBV.</p><p id="par0040" class="elsevierStylePara elsevierViewall">Given the age of the patient, the rarity of the presentation and the consanguinity of the parents, genetic testing was performed for screening of primary haemophagocytic syndromes, confirming the presence of two pathogenic heterozygous variants—nonsense variant c.1284<span class="elsevierStyleHsp" style=""></span>G<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>A p.(Trp428Ter) and missense variant c.1349C<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>T p.(Thr450Met)—in gene <span class="elsevierStyleItalic">PRF1</span> (which encodes perforin, a protein involved in the function of cytotoxic NK and T cells and associated with familial haemophagocytic lymphohistiocytosis type 2) and a heterozygous variant of uncertain significance—c. 3220C<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>T p.(Arg1074Tr)—in gene <span class="elsevierStyleItalic">UNC13D</span> (a variant that affects degranulation and causes Munc13-4 deficiency, which is associated with the onset of the disease from age 2 years). Flow cytometric analysis confirmed a perforin expression of 3%, impaired cytotoxicity and normal degranulation. The presence of a pathogenic variant was confirmed in both parents, each of whom contributed one variant to the child—c. 1349C<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>T p. (Thr450Met) in the mother, and c.1284<span class="elsevierStyleHsp" style=""></span>G<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>A p.(Trp428Ter) in the father.</p><p id="par0045" class="elsevierStylePara elsevierViewall">The final diagnosis was familial haemophagocytic lymphohistiocytosis (FHL) type 2, and, following a review of the literature, the patient, stable at the time, was referred to a reference centre to search for a donor and performance of haematopoietic stem cell transplantation.</p><p id="par0050" class="elsevierStylePara elsevierViewall">The clinical and laboratory features were consistent with the pathophysiology of FHL.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Fever results from the increased levels of IL-6. Splenomegaly, lymphocyte and macrocyte infiltration and cytopenias result from elevated levels of tumour necrosis factor α (TNF-α), and interferon γ (IFN-γ) as well as direct haemophagocytosis. Hypertriglyceridemia is attributed to the reduction in lipoprotein lipase activity resulting from the elevation of TNF-α levels and activated lymphocytes produce high concentrations of soluble IL-2 receptor.<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2,3</span></a></p><p id="par0055" class="elsevierStylePara elsevierViewall">The initial clinical manifestations were similar to those found in any severe infection. There was a prolonged high fever and progressive pancytopenia and hepatosplenomegaly associated with features suggestive of multiple organ failure. In the complete blood count and chemistry panel, the presence of cytopenias, coagulopathy with hypofibrinogenaemia, hypertriglyceridemia, hypertransaminasaemia and hyperferritinaemia supported the suspected diagnosis (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). These findings correspond to the clinical and laboratory criteria required for diagnosis established in 1991 and updated in 2004. Therefore, FHL should be included in the differential diagnosis of patients with fever of unknown source, acute liver failure, hepatitis with coagulopathy or sepsis with multiple organ failure.<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3,4</span></a></p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0060" class="elsevierStylePara elsevierViewall">The treatment options include steroids, immunosuppressants, cytostatic agents, immunomodulators, biological agents or monoclonal antibodies, depending on the case, but in the case of a genetic aetiology, haematopoietic stem cell transplantation is the curative treatment used to correct the impairment in cytotoxic function.<a class="elsevierStyleCrossRefs" href="#bib0025"><span class="elsevierStyleSup">5,6</span></a></p><p id="par0065" class="elsevierStylePara elsevierViewall">There are very severe forms of disease with fulminant progression that require specific treatment and intensive supportive care on an empiric and urgent basis, while other forms develop more slowly or have a recurrent course and respond to less aggressive supportive care while awaiting definitive treatment, as was the case of our patient.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflicts of interest</span><p id="par0070" class="elsevierStylePara elsevierViewall">The authors have no conflicts of interest to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflicts of interest" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:1 [ 0 => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 832 "Ancho" => 2923 "Tamanyo" => 182323 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0145" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Proposed diagnostic algorithm for FLH.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:6 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hemophagocytic lymphohistiocytosis: review of etiologies and management" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M.R. George" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2147/JBM.S46255" "Revista" => array:6 [ "tituloSerie" => "J Blood Med" "fecha" => "2014" "volumen" => "5" "paginaInicial" => "69" "paginaFinal" => "86" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24966707" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnostic Challenges in Pediatric Hemophagocytic Lymphohistiocytosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.J. Si" 1 => "S.K. Tasian" 2 => "H. Bassiri" 3 => "B.T. Fisher" 4 => "J. Atalla" 5 => "R. Patel" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10875-021-01025-3" "Revista" => array:6 [ "tituloSerie" => "J Clin Immunol" "fecha" => "2021" "volumen" => "41" "paginaInicial" => "1213" "paginaFinal" => "1218" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33761058" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Síndromes hemofagocíticos (I): concepto, clasificación, fisiopatología y clínica" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "A. Pérez-Martínez" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "An Pediatr Contin" "fecha" => "2013" "volumen" => "11" "paginaInicial" => "237" "paginaFinal" => "244" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "E. Brisse" 1 => "C.H. Wouters" 2 => "P. Matthys" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/bjh.14147" "Revista" => array:6 [ "tituloSerie" => "Br J Haematol" "fecha" => "2016" "volumen" => "174" "paginaInicial" => "203" "paginaFinal" => "217" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27264204" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F. Locatelli" 1 => "M.B. Jordan" 2 => "C. Allen" 3 => "S. Cesaro" 4 => "C. Rizzari" 5 => "A. Rao" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa1911326" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2020" "volumen" => "382" "paginaInicial" => "1811" "paginaFinal" => "1822" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32374962" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Síndromes hemofagocíticos: la importancia del diagnóstico y tratamiento precoces" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "I. Astigarraga" 1 => "L.I. Gonzalez-Granado" 2 => "L.M. Allende" 3 => "L. Alsina" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "An Pediatr" "fecha" => "2018" "volumen" => "89" "paginaInicial" => "124.e1" "paginaFinal" => "124.e8" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/23412879/0000009900000005/v1_202311240521/S2341287923002235/v1_202311240521/en/main.assets" "Apartado" => array:4 [ "identificador" => "38181" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Scientific letters" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23412879/0000009900000005/v1_202311240521/S2341287923002235/v1_202311240521/en/main.pdf?idApp=UINPBA00005H&text.app=https://analesdepediatria.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287923002235?idApp=UINPBA00005H" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 2 | 5 | 7 |
| 2024 October | 41 | 35 | 76 |
| 2024 September | 42 | 32 | 74 |
| 2024 August | 51 | 40 | 91 |
| 2024 July | 38 | 19 | 57 |
| 2024 June | 43 | 22 | 65 |
| 2024 May | 49 | 41 | 90 |
| 2024 April | 39 | 19 | 58 |
| 2024 March | 40 | 24 | 64 |
| 2024 February | 28 | 34 | 62 |
| 2024 January | 35 | 30 | 65 |
| 2023 December | 58 | 29 | 87 |
| 2023 November | 104 | 52 | 156 |
| 2023 October | 60 | 27 | 87 |
Show all
